1. Home
  2. BDSX vs REFR Comparison

BDSX vs REFR Comparison

Compare BDSX & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

BUY

Current Price

$15.77

Market Cap

122.0M

Sector

Health Care

ML Signal

BUY

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$1.03

Market Cap

33.6M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
REFR
Founded
2005
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
33.6M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
BDSX
REFR
Price
$15.77
$1.03
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
127.3K
36.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
$88,499,000.00
$1,488,642.00
Revenue This Year
$22.01
N/A
Revenue Next Year
$26.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$0.93
52 Week High
$17.40
$2.70

Technical Indicators

Market Signals
Indicator
BDSX
REFR
Relative Strength Index (RSI) 73.20 36.50
Support Level $6.33 $0.98
Resistance Level N/A $1.28
Average True Range (ATR) 1.71 0.08
MACD 0.29 0.01
Stochastic Oscillator 74.31 12.39

Price Performance

Historical Comparison
BDSX
REFR

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: